Effects of dietary vitamins on obesity-related metabolic parameters

被引:9
|
作者
Lee, Chooi Yeng [1 ]
机构
[1] Monash Univ Malaysia, Sch Pharm, Subang Jaya 47500, Selangor, Malaysia
来源
关键词
Adipogenesis; Anti-inflammatory; Antioxidant; Diet; Obesity; Vitamin; NF-KAPPA-B; BETA-CAROTENE; C SUPPLEMENTATION; ADIPOSE-TISSUE; WEIGHT-LOSS; INSULIN-RESISTANCE; DIABETES-MELLITUS; ADULTS; ALPHA; CHOLECALCIFEROL;
D O I
10.1017/jns.2023.30
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Type 2 diabetes mellitus (T2DM) is one of the leading causes of death worldwide. Genetic factors, some underlying medical conditions, and obesity are risk factors of T2DM. Unlike other risk factors which are non-modifiable, obesity is preventable and usually treatable, and is largely contributed by lifestyle factors. Management of these lifestyle factors may curb the development of T2DM and reduces T2DM prevalence. Dietary vitamins have been recommended as a lifestyle modification intervention to support obesity treatment. Vitamins correlate negatively with body weight, body mass index and body composition. Some of the vitamins may also have anti-adipogenic, anti-inflammatory and antioxidant effects. However, results from pre-clinical and clinical studies of the effects of vitamins on obesity are inconsistent. A clear understanding of the effects of vitamins on obesity will help determine dietary intervention that is truly effective in preventing and treating obesity as well as obesity-related complications including T2DM. This article reviews existing evidences of the effects of vitamin supplementation on obesity and obesity-related metabolic status.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Evaluation of Metabolic Risk Marker in Obesity-related Glomerulopathy
    Chen, Hui-Mei
    Chen, Yan
    Zhang, Yi-De
    Zhang, Pei-Pei
    Chen, Hui-Ping
    Wang, Qing-Wen
    Li, Lei-Shi
    Liu, Zhi-Hong
    JOURNAL OF RENAL NUTRITION, 2011, 21 (04) : 309 - 315
  • [22] Role of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction
    Bouter, Kristien E.
    van Raalte, Daniel H.
    Groen, Albert K.
    Nieuwdorp, Max
    GASTROENTEROLOGY, 2017, 152 (07) : 1671 - 1678
  • [23] No Role for Mast Cells in Obesity-Related Metabolic Dysregulation
    Chmelar, Jindrich
    Chatzigeorgiou, Antonios
    Chung, Kyoung-Jin
    Prucnal, Marta
    Voehringer, David
    Roers, Axel
    Chavakis, Triantafyllos
    FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [24] Ginsenoside Rg1 inhibits dietary-induced obesity and improves obesity-related glucose metabolic disorders
    Li, Jin-bo
    Zhang, Rui
    Han, Xiao
    Piao, Chun-li
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2018, 51 (04)
  • [25] The association of aldosterone with obesity-related hypertension and the metabolic syndrome
    Vogt, Bruno
    Bochud, Murielle
    Burnier, Michel
    SEMINARS IN NEPHROLOGY, 2007, 27 (05) : 529 - 537
  • [26] THE ROLE OF OXIDATIVE STRESS IN THE DEVELOPMENT OF OBESITY AND OBESITY-RELATED METABOLIC DISORDERS
    Colak, Emina
    Pap, Dragana
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2021, 40 (01) : 1 - 9
  • [27] Overweight and obesity-related metabolic disorders in hospital employees
    Hwang, LC
    Tsai, CH
    Chen, THH
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2006, 105 (01) : 56 - 63
  • [28] CNTF: a target therapeutic for obesity-related metabolic disease?
    Vance B. Matthews
    Mark A. Febbraio
    Journal of Molecular Medicine, 2008, 86 : 353 - 361
  • [29] Pediatric Obesity-Related Asthma: The Role of Metabolic Dysregulation
    Vijayakanthi, Nandini
    Greally, John M.
    Rastogi, Deepa
    PEDIATRICS, 2016, 137 (05)
  • [30] Intestinal MYC modulates obesity-related metabolic dysfunction
    Yuhong Luo
    Shoumei Yang
    Xuan Wu
    Shogo Takahashi
    Lulu Sun
    Jie Cai
    Kristopher W. Krausz
    Xiaozhen Guo
    Henrique B. Dias
    Oksana Gavrilova
    Cen Xie
    Changtao Jiang
    Weiwei Liu
    Frank J. Gonzalez
    Nature Metabolism, 2021, 3 : 923 - 939